Retrospective analysis on efficacy of convalescent plasma in acute respiratory distress syndrome due to COVID-19
Open Access
- 27 August 2021
- journal article
- conference paper
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 140 (1) , 12-16
Abstract
BACKGROUND: Coronavirus disease 2019 (COVID-19) is an ongoing global health threat. However, currently, no standard therapy has been approved for the disease. OBJECTIVES: To evaluate the clinical effectiveness of convalescent plasma (CP) in patients with acute respiratory distress syndrome (ARDS) due to COVID-19. DESIGN AND SETTING: Retrospective study conducted at Kayseri City Education and Research Hospital, Kayseri, Turkey. METHODS: The case group consisted of adult patients (> 18 years) with ARDS due to COVID-19 who received CP in combination with antiviral and supportive treatment. These patients were compared with others who only received antiviral and supportive treatment. RESULTS: During the study period, a total of 30 patients with ARDS due to COVID-19 were included. Eleven patients (36%) received CP in combination with antiviral and supportive treatment, whereas nineteen patients (64%) in the control group only received antiviral and supportive treatment. On admission, the median age, demographic and clinical data and initial laboratory test results were similar between the groups (P > 0.05). On the 14th day of treatment, the laboratory values remained similar between the groups (P > 0.05). The mortality rates were not significantly different between the groups. CONCLUSION: CP treatment did not affect mortality or lead to clinical improvement for COVID-19 patients with ARDS.Keywords
This publication has 13 references indexed in Scilit:
- Perspectives for immune plasma treatment of COVID-19TURKISH JOURNAL OF MEDICAL SCIENCES, 2021
- Evidence favouring the efficacy of convalescent plasma for COVID-19 therapymedRxiv, 2020
- Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trialHaematologica, 2020
- Treatment with convalescent plasma for COVID‐19 patients in Wuhan, ChinaJournal of Medical Virology, 2020
- Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19JAMA, 2020
- WHO Declares COVID-19 a Pandemic2020
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2Nature Microbiology, 2020
- Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in KoreaJournal of Korean Medical Science, 2020
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysisThe Journal of Infectious Diseases, 2014
- Acute Respiratory Distress SyndromeJAMA, 2012